Spasticity.
作者信息
Rush Raphael, Kumbhare Dinesh
机构信息
Department of Internal Medicine (Rush), University of Toronto; Department of Physical Medicine and Rehabilitation, Toronto Rehabilitation Institute, and University of Toronto (Kumbhare), Toronto, Ont.
出版信息
CMAJ. 2015 Apr 7;187(6):436. doi: 10.1503/cmaj.140405. Epub 2014 Nov 17.
Abstract
摘要
相似文献
1
Spasticity.
CMAJ. 2015 Apr 7;187(6):436. doi: 10.1503/cmaj.140405. Epub 2014 Nov 17.
2
Botulinum toxin and spasticity.
J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):143-7. doi: 10.1136/jnnp.69.2.143.
3
The management of cerebral palsy: subjectivity and a conundrum.
J Child Neurol. 1996 Mar;11(2):75-76. doi: 10.1177/088307389601100201.
4
The use of botulinum toxin and intrathecal baclofen in hip dysplasia in cerebral palsy.
Dev Med Child Neurol. 2023 Aug;65(8):1125. doi: 10.1111/dmcn.15642. Epub 2023 May 20.
5
[Treatment of spasticity].
Duodecim. 1999;115(8):877-85.
6
New approaches to managing spasticity in children with cerebral palsy.
West J Med. 1997 Apr;166(4):271.
7
Spasticity in children and young people with non-progressive brain disorders: summary of NICE guidance.
BMJ. 2012 Jul 26;345:e4845. doi: 10.1136/bmj.e4845.
8
Pharmacologic interventions for reducing spasticity in cerebral palsy.
Indian J Pediatr. 2005 Oct;72(10):869-72. doi: 10.1007/BF02731118.
9
[Spasticity in children cerebral palsy: diagnosis and treatment strategies].
Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(7 Pt 2):24-8.
10
The treatment of cerebral palsy: What we know, what we don't know.
J Pediatr. 2004 Aug;145(2 Suppl):S42-6. doi: 10.1016/j.jpeds.2004.05.022.
引用本文的文献
1
Current techniques for the treatment of spasticity and their effectiveness.
EFORT Open Rev. 2025 May 5;10(5):237-249. doi: 10.1530/EOR-2024-0156.
2
Efficacy of botulinum toxin A combined with extracorporeal shockwave therapy in post-stroke spasticity: a systematic review.
Front Neurol. 2024 Mar 15;15:1342545. doi: 10.3389/fneur.2024.1342545. eCollection 2024.
本文引用的文献
1
The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.
Clin Rehabil. 2013 Dec;27(12):1084-96. doi: 10.1177/0269215513491274. Epub 2013 Jul 17.
2
Revisiting physiologic and psychologic triggers that increase spasticity.
Am J Phys Med Rehabil. 2013 Apr;92(4):357-69. doi: 10.1097/phm.0b013e31827d68a4.
3
Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
Clin Ther. 2010 Dec;32(14):2282-303. doi: 10.1016/j.clinthera.2011.01.005.
4
Time-course and determinants of spasticity during the first six months following first-ever stroke.
J Rehabil Med. 2010 Apr;42(4):296-301. doi: 10.2340/16501977-0509.
5
Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration.
Pediatrics. 2008 Mar;121(3):547-54. doi: 10.1542/peds.2007-1270.
6
Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review.
Neurology. 2004 Oct 26;63(8):1357-63. doi: 10.1212/01.wnl.0000141863.52691.44.
7
Prevalence and treatment of spasticity reported by multiple sclerosis patients.
Mult Scler. 2004 Oct;10(5):589-95. doi: 10.1191/1352458504ms1085oa.
8
Anti-spasticity agents for multiple sclerosis.
Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332.
9
Epidemiology of spasticity following traumatic spinal cord injury.
Arch Phys Med Rehabil. 1990 Jul;71(8):566-9.
Zotero 插件